PARP inhibitor activates the intrinsic pathway of apoptosis in primary lung cancer cells
{{output}}
This investigation was aimed to see whether PJ34(TM), a PARP inhibitor, could exert cytotoxicity in six nonsmall cell lung cancer cell lines developed from surgically resected tissues. Using various biochemical assays, we have seen that PJ34(TM) effects are co... ...